Seeking Alpha

Par Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M...

Par Pharmaceutical (PRX +5%) agrees to acquire privately held Anchen Pharmaceuticals for $410M in cash, a move that will boost the generic drug maker's current pipeline and add to its R&D capabilities.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)